Vaxart, Inc. (VXRT)
USD 0.31
(-1.48%)
USD 0.31
(-1.48%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -60.76 Million USD | 191.11% |
| 2022 | -3.16 Million USD | 93.4% |
| 2021 | -47.85 Million USD | -202.57% |
| 2020 | -15.81 Million USD | -238.11% |
| 2019 | -4.67 Million USD | 64.33% |
| 2018 | -13.11 Million USD | -101.29% |
| 2017 | -6.51 Million USD | 25.4% |
| 2016 | -8.73 Million USD | -194.93% |
| 2015 | 9.2 Million USD | -56.19% |
| 2014 | 21 Million USD | 19.32% |
| 2013 | 17.6 Million USD | 26.62% |
| 2012 | 13.9 Million USD | 3.93% |
| 2011 | 13.37 Million USD | -56.93% |
| 2010 | 31.05 Million USD | 265.3% |
| 2009 | 8.5 Million USD | 0.0% |
| 2008 | - USD | 0.0% |
| 2007 | - USD | -100.0% |
| 2006 | 27.15 Million USD | -33.5% |
| 2005 | 40.83 Million USD | -24.53% |
| 2004 | 54.11 Million USD | -43.17% |
| 2003 | 95.21 Million USD | 25.24% |
| 2002 | 76.02 Million USD | -7.53% |
| 2001 | 82.21 Million USD | 8.14% |
| 2000 | 76.02 Million USD | -3.03% |
| 1999 | 78.4 Million USD | 2.89% |
| 1998 | 76.2 Million USD | 38.8% |
| 1997 | 54.9 Million USD | -16.69% |
| 1996 | 65.9 Million USD | 22.26% |
| 1995 | 53.9 Million USD | 58.53% |
| 1994 | 34 Million USD | 49.12% |
| 1993 | 22.8 Million USD | 62.86% |
| 1992 | 14 Million USD | 35.92% |
| 1991 | 10.3 Million USD | -8.04% |
| 1990 | 11.2 Million USD | 33.33% |
| 1989 | 8.4 Million USD | 47.37% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 1.08 Million USD | -47.14% |
| 2024 Q2 | 5.3 Million USD | -1124.88% |
| 2023 Q3 | -754 Thousand USD | -426.41% |
| 2023 Q1 | -402 Thousand USD | 57.46% |
| 2023 Q2 | 231 Thousand USD | 157.46% |
| 2023 Q4 | 2.04 Million USD | 371.22% |
| 2023 FY | 2.87 Million USD | 191.11% |
| 2022 Q1 | -18.11 Million USD | -17.22% |
| 2022 Q4 | -945 Thousand USD | -14.27% |
| 2022 Q3 | -827 Thousand USD | -5.48% |
| 2022 Q2 | -784 Thousand USD | 95.67% |
| 2022 FY | -3.16 Million USD | 93.4% |
| 2021 Q1 | -9.56 Million USD | -16.17% |
| 2021 Q2 | -10.62 Million USD | -11.06% |
| 2021 FY | -47.85 Million USD | -202.57% |
| 2021 Q4 | -15.45 Million USD | -26.6% |
| 2021 Q3 | -12.2 Million USD | -14.91% |
| 2020 Q1 | 1.36 Million USD | 117.6% |
| 2020 Q2 | -4.59 Million USD | -437.57% |
| 2020 Q4 | -8.23 Million USD | -89.27% |
| 2020 Q3 | -4.35 Million USD | 5.23% |
| 2020 FY | -15.81 Million USD | -238.11% |
| 2019 Q1 | 1.57 Million USD | 158.29% |
| 2019 Q2 | -3.62 Million USD | -329.53% |
| 2019 Q3 | -3.25 Million USD | 10.02% |
| 2019 Q4 | 625 Thousand USD | 119.18% |
| 2019 FY | -4.67 Million USD | 64.33% |
| 2018 Q4 | -2.7 Million USD | 33.98% |
| 2018 FY | -13.11 Million USD | -101.29% |
| 2018 Q1 | -1.9 Million USD | -339.62% |
| 2018 Q2 | -4.4 Million USD | -131.18% |
| 2018 Q3 | -4.1 Million USD | 6.9% |
| 2017 FY | -6.51 Million USD | 25.4% |
| 2017 Q3 | -2.14 Million USD | 49.17% |
| 2017 Q4 | 795 Thousand USD | 137.03% |
| 2017 Q2 | -4.22 Million USD | -513.71% |
| 2017 Q1 | 1.02 Million USD | 143.34% |
| 2016 FY | -8.73 Million USD | -194.93% |
| 2016 Q4 | -2.35 Million USD | -2456.0% |
| 2016 Q3 | 100 Thousand USD | -80.0% |
| 2016 Q2 | 500 Thousand USD | -90.57% |
| 2016 Q1 | 5.3 Million USD | 211.76% |
| 2015 FY | 9.2 Million USD | -56.19% |
| 2015 Q4 | 1.7 Million USD | 0.0% |
| 2015 Q1 | 5.6 Million USD | -54.47% |
| 2015 Q2 | 4.1 Million USD | -26.79% |
| 2015 Q3 | 1.7 Million USD | -58.54% |
| 2014 Q3 | -1 Million USD | 23.08% |
| 2014 Q1 | 10.2 Million USD | 43.66% |
| 2014 Q4 | 12.3 Million USD | 1330.0% |
| 2014 FY | 21 Million USD | 19.32% |
| 2014 Q2 | -1.3 Million USD | -112.75% |
| 2013 Q2 | 1.58 Million USD | -81.14% |
| 2013 FY | 17.6 Million USD | 26.62% |
| 2013 Q4 | 7.1 Million USD | 343.75% |
| 2013 Q3 | 1.6 Million USD | 0.95% |
| 2013 Q1 | 8.4 Million USD | 154.76% |
| 2012 FY | 13.9 Million USD | 3.93% |
| 2012 Q2 | 631 Thousand USD | -0.16% |
| 2012 Q3 | 632 Thousand USD | 0.16% |
| 2012 Q1 | 632 Thousand USD | -28.99% |
| 2012 Q4 | 3.29 Million USD | 421.84% |
| 2011 Q4 | 890 Thousand USD | 19.95% |
| 2011 Q1 | 8.54 Million USD | 278.73% |
| 2011 Q2 | 3.19 Million USD | -62.62% |
| 2011 Q3 | 742 Thousand USD | -76.78% |
| 2011 FY | 13.37 Million USD | -56.93% |
| 2010 Q3 | 11.49 Million USD | 171.42% |
| 2010 FY | 31.05 Million USD | 265.3% |
| 2010 Q4 | 2.25 Million USD | -80.36% |
| 2010 Q2 | 4.23 Million USD | -67.61% |
| 2010 Q1 | 13.07 Million USD | 53.76% |
| 2009 FY | 8.5 Million USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2009 Q4 | 8.5 Million USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2007 Q3 | 5.41 Million USD | -41.09% |
| 2007 Q4 | - USD | -100.0% |
| 2007 Q1 | 9 Million USD | -23.24% |
| 2007 Q2 | 9.19 Million USD | 2.04% |
| 2007 FY | - USD | -100.0% |
| 2006 Q4 | 11.73 Million USD | 179.05% |
| 2006 FY | 27.15 Million USD | -33.5% |
| 2006 Q3 | 4.2 Million USD | -29.99% |
| 2006 Q2 | 6 Million USD | 18.52% |
| 2006 Q1 | 5.06 Million USD | 89.64% |
| 2005 Q2 | 10.03 Million USD | 11.27% |
| 2005 FY | 40.83 Million USD | -24.53% |
| 2005 Q1 | 9.01 Million USD | -72.9% |
| 2005 Q4 | 2.67 Million USD | -69.84% |
| 2005 Q3 | 8.86 Million USD | -11.63% |
| 2004 Q4 | 33.26 Million USD | 26.56% |
| 2004 Q3 | 26.27 Million USD | -13.9% |
| 2004 Q1 | 22.57 Million USD | -47.65% |
| 2004 Q2 | 30.52 Million USD | 35.21% |
| 2004 FY | 54.11 Million USD | -43.17% |
| 2003 FY | 95.21 Million USD | 25.24% |
| 2003 Q4 | 43.12 Million USD | 106.23% |
| 2003 Q3 | 20.91 Million USD | 43.83% |
| 2003 Q2 | 14.53 Million USD | -12.64% |
| 2003 Q1 | 16.64 Million USD | -44.36% |
| 2002 Q4 | 29.91 Million USD | 92.99% |
| 2002 Q1 | 15.48 Million USD | -41.27% |
| 2002 Q2 | 16.49 Million USD | 6.54% |
| 2002 Q3 | 15.49 Million USD | -6.04% |
| 2002 FY | 76.02 Million USD | -7.53% |
| 2001 FY | 82.21 Million USD | 8.14% |
| 2001 Q4 | 26.36 Million USD | 58.06% |
| 2001 Q3 | 16.67 Million USD | -18.74% |
| 2001 Q2 | 20.52 Million USD | 12.65% |
| 2001 Q1 | 18.21 Million USD | -25.91% |
| 2000 Q4 | 24.59 Million USD | 100.11% |
| 2000 FY | 76.02 Million USD | -3.03% |
| 2000 Q1 | 19.9 Million USD | -14.2% |
| 2000 Q2 | 19.74 Million USD | -0.81% |
| 2000 Q3 | 12.28 Million USD | -37.76% |
| 1999 FY | 78.4 Million USD | 2.89% |
| 1999 Q4 | 23.2 Million USD | 24.73% |
| 1999 Q3 | 18.6 Million USD | -13.88% |
| 1999 Q1 | 15.52 Million USD | -21.99% |
| 1999 Q2 | 21.59 Million USD | 39.14% |
| 1998 FY | 76.2 Million USD | 38.8% |
| 1998 Q1 | 16.1 Million USD | 56.31% |
| 1998 Q2 | 20 Million USD | 24.22% |
| 1998 Q4 | 19.9 Million USD | 4.19% |
| 1998 Q3 | 19.1 Million USD | -4.5% |
| 1997 Q1 | 14.4 Million USD | -17.24% |
| 1997 Q3 | 11.9 Million USD | -31.61% |
| 1997 Q4 | 10.3 Million USD | -13.45% |
| 1997 FY | 54.9 Million USD | -16.69% |
| 1997 Q2 | 17.4 Million USD | 20.83% |
| 1996 FY | 65.9 Million USD | 22.26% |
| 1996 Q2 | 16.6 Million USD | 5.06% |
| 1996 Q3 | 15.1 Million USD | -9.04% |
| 1996 Q4 | 17.4 Million USD | 15.23% |
| 1996 Q1 | 15.8 Million USD | -24.04% |
| 1995 Q3 | 11.7 Million USD | 5.41% |
| 1995 Q4 | 20.8 Million USD | 77.78% |
| 1995 Q1 | 10.4 Million USD | 65.08% |
| 1995 Q2 | 11.1 Million USD | 6.73% |
| 1995 FY | 53.9 Million USD | 58.53% |
| 1994 Q2 | 8.7 Million USD | 3.57% |
| 1994 FY | 34 Million USD | 49.12% |
| 1994 Q4 | 6.3 Million USD | -35.05% |
| 1994 Q1 | 8.4 Million USD | -10.64% |
| 1994 Q3 | 9.7 Million USD | 11.49% |
| 1993 Q3 | 4.5 Million USD | -23.73% |
| 1993 Q4 | 9.4 Million USD | 108.89% |
| 1993 Q1 | 3.7 Million USD | -37.29% |
| 1993 Q2 | 5.9 Million USD | 59.46% |
| 1993 FY | 22.8 Million USD | 62.86% |
| 1992 Q1 | 2.9 Million USD | 7.41% |
| 1992 Q4 | 5.9 Million USD | 210.53% |
| 1992 FY | 14 Million USD | 35.92% |
| 1992 Q2 | 3.8 Million USD | 31.03% |
| 1992 Q3 | 1.9 Million USD | -50.0% |
| 1991 Q4 | 2.7 Million USD | 12.5% |
| 1991 FY | 10.3 Million USD | -8.04% |
| 1991 Q1 | 2.5 Million USD | -3.85% |
| 1991 Q2 | 2.6 Million USD | 4.0% |
| 1991 Q3 | 2.4 Million USD | -7.69% |
| 1990 FY | 11.2 Million USD | 33.33% |
| 1990 Q4 | 2.6 Million USD | -10.34% |
| 1990 Q3 | 2.9 Million USD | -3.33% |
| 1990 Q2 | 3 Million USD | 11.11% |
| 1990 Q1 | 2.7 Million USD | -12.9% |
| 1989 Q4 | 3.1 Million USD | 55.0% |
| 1989 FY | 8.4 Million USD | 47.37% |
| 1989 Q1 | 13.6 Million USD | 20.35% |
| 1989 Q3 | 2 Million USD | 5.26% |
| 1989 Q2 | 1.9 Million USD | -86.03% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Akebia Therapeutics, Inc. | 120.47 Million USD | 150.437% |
| Jaguar Health, Inc. | 7.72 Million USD | 886.678% |
| Keros Therapeutics, Inc. | -664 Thousand USD | -9051.054% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | -1215160.0% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 104.003% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | 150.74% |
| ContextLogic Inc. | 59 Million USD | 202.988% |
| MiMedx Group, Inc. | 266.84 Million USD | 122.771% |
| MEI Pharma, Inc. | 49.32 Million USD | 223.184% |
| AlloVir, Inc. | -398 Thousand USD | -15167.085% |
| Novavax, Inc. | 639.93 Million USD | 109.495% |
| Aptorum Group Limited | -1.11 Million USD | -5351.122% |
| Ardelyx, Inc. | 106.66 Million USD | 156.968% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | 125.241% |
| Psyence Biomedical Ltd. | -240.00 USD | -25317816.667% |
| Vaxcyte, Inc. | -75 Million USD | 18.983% |
| Precigen, Inc. | 106 Thousand USD | 57423.585% |
| Pharming Group N.V. | 220.1 Million USD | 127.606% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | 11898.641% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | 6122.101% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | 155.354% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 66.505% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | -11658.775% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | Infinity% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | Infinity% |
| Bicycle Therapeutics plc | -129.52 Million USD | 53.086% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | -34.061% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | -176.359% |
| Acelyrin, Inc. | -115 Thousand USD | -52737.391% |
| SELLAS Life Sciences Group, Inc. | - USD | Infinity% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | -10541.506% |
| Senti Biosciences, Inc. | -2.68 Million USD | -2164.741% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | 1599.951% |
| AbCellera Biologics Inc. | 38.02 Million USD | 259.798% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | -1166.424% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | 50735.833% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | 308.6% |
| Chimerix, Inc. | 324 Thousand USD | 18854.012% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | 12350.605% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | -74001.22% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | -94.955% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | -12250.203% |
| Elevation Oncology, Inc. | -39 Thousand USD | -155702.564% |
| Alkermes plc | 1.37 Billion USD | 104.42% |
| Fortress Biotech, Inc. | 57.85 Million USD | 205.03% |
| Fortress Biotech, Inc. | 57.85 Million USD | 205.03% |
| Agenus Inc. | 139.61 Million USD | 143.522% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | 466.55% |
| Dyadic International, Inc. | 922.95 Thousand USD | 6683.514% |
| ImmuCell Corporation | 4.39 Million USD | 1482.145% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | 388.51% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 42.743% |
| Lantern Pharma Inc. | -174.84 Thousand USD | -34652.893% |
| Immix Biopharma, Inc. | -5468.00 USD | -1111147.257% |
| Incyte Corporation | 3.44 Billion USD | 101.766% |
| IO Biotech, Inc. | -756 Thousand USD | -7937.434% |
| Janux Therapeutics, Inc. | -46.83 Million USD | -29.727% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | -354.886% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | -137410.184% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 38.134% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | -110378.182% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | 7676.434% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | -11429.981% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | 306.768% |
| NextCure, Inc. | -3.68 Million USD | -1549.376% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | 419.083% |
| Onconetix, Inc. | -1.12 Million USD | -5290.781% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | -109.759% |
| Opthea Limited | 21.72 Thousand USD | 279855.985% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | -105895.534% |
| PureTech Health plc | -1.6 Million USD | -3690.58% |
| Pyxis Oncology, Inc. | -2 Million USD | -2938.15% |
| Seer, Inc. | 7.02 Million USD | 964.708% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | -604446.811% |
| Clearside Biomedical, Inc. | 7.87 Million USD | 871.986% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | -1441.407% |
| VYNE Therapeutics Inc. | 424 Thousand USD | 14430.896% |
| Wave Life Sciences Ltd. | 104.09 Million USD | 158.37% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | 144.92% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 37.325% |
| ChromaDex Corporation | 50.78 Million USD | 219.659% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | -26090.948% |
| Caribou Biosciences, Inc. | -77.59 Million USD | 21.695% |
| CRISPR Therapeutics AG | 240.95 Million USD | 125.217% |
| Precision BioSciences, Inc. | 40.47 Million USD | 250.136% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 38.1% |
| Innoviva, Inc. | 261.06 Million USD | 123.275% |
| Summit Therapeutics Inc. | -2.05 Million USD | -2864.049% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | 1487.917% |
| Aadi Bioscience, Inc. | 21.54 Million USD | 382.028% |
| ESSA Pharma Inc. | -118.49 Thousand USD | -51180.688% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | -42302.356% |
| GT Biopharma, Inc. | - USD | Infinity% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | 10077.504% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | 119.372% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | 2460.645% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | -119653.646% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | -756.058% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | -12704.476% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | -584159.615% |
| Soligenix, Inc. | 97.31 Thousand USD | 62542.067% |
| Century Therapeutics, Inc. | -10.8 Million USD | -462.152% |
| Kura Oncology, Inc. | -849 Thousand USD | -7057.008% |
| TScan Therapeutics, Inc. | -67.1 Million USD | 9.45% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | -41235.374% |
| Ocean Biomedical, Inc. | - USD | Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | 161.353% |
| Autolus Therapeutics plc | -4.86 Million USD | -1148.469% |
| Mineralys Therapeutics, Inc. | - USD | Infinity% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | 246.82% |
| Eterna Therapeutics Inc. | -168 Thousand USD | -36068.452% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | 164.148% |
| GRI Bio, Inc. | 10.84 Million USD | 660.493% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | 2492.257% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | -599.47% |
| IGM Biosciences, Inc. | -211.66 Million USD | 71.292% |
| INmune Bio, Inc. | 155 Thousand USD | 39301.935% |
| Heron Therapeutics, Inc. | 61.93 Million USD | 198.101% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | -3933.948% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | -9270.441% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | -207466.441% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | 15215.174% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | -2944.238% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | -19313.099% |
| Coherus BioSciences, Inc. | 94.46 Million USD | 164.326% |
| Verastem, Inc. | -62 Thousand USD | -97904.839% |
| Abeona Therapeutics Inc. | 2.43 Million USD | 2595.4% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | -23180.843% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | 2107.367% |
| Histogen Inc. | 3.76 Million USD | 1712.178% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | 10645.855% |
| Surrozen, Inc. | -27.23 Million USD | -123.147% |
| Organovo Holdings, Inc. | -5.38 Million USD | -1027.538% |
| Lixte Biotechnology Holdings, Inc. | - USD | Infinity% |
| Ovid Therapeutics Inc. | -1.2 Million USD | -4943.075% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | -136.92% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | 403.027% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | -3068738.384% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | 1101.628% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | -90414.07% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | 139.255% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | 41775.583% |
| Apollomics, Inc. | 127 Thousand USD | 47944.882% |
| Amarin Corporation plc | 165.54 Million USD | 136.706% |
| Mesoblast Limited | -9.81 Million USD | -519.083% |
| Turnstone Biologics Corp. | 16.5 Million USD | 468.127% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 45.005% |
| Synaptogenix, Inc. | -6347.00 USD | -957249.929% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | -119043.137% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | 137.656% |
| BriaCell Therapeutics Corp. | - USD | Infinity% |
| Monopar Therapeutics Inc. | - USD | Infinity% |
| Exelixis, Inc. | 1.75 Billion USD | 103.457% |
| Better Therapeutics, Inc. | -2.72 Million USD | -2126.567% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 45.825% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | 117.973% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | -532534.993% |
| Dermata Therapeutics, Inc. | - USD | Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | -870.655% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | -5384.025% |
| TNF Pharmaceuticals, Inc. | - USD | Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | 930.322% |
| Insmed Incorporated | 239.63 Million USD | 125.356% |
| Virpax Pharmaceuticals, Inc. | - USD | Infinity% |
| MediWound Ltd. | 3.57 Million USD | 1798.239% |
| OmniAb, Inc. | 14.66 Million USD | 514.284% |
| Alector, Inc. | -95.05 Million USD | 36.075% |
| Seres Therapeutics, Inc. | 125.62 Million USD | 148.37% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | -39.804% |
| Zai Lab Limited | 170.9 Million USD | 135.554% |
| Revance Therapeutics, Inc. | 81.87 Million USD | 174.213% |
| Aura Biosciences, Inc. | -1.29 Million USD | -4592.124% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | 46840.769% |
| Immunic, Inc. | -111 Thousand USD | -54641.441% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | 483.266% |
| Veracyte, Inc. | 248.14 Million USD | 124.487% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 99.131% |
| FibroGen, Inc. | 128.9 Million USD | 147.138% |
| SeaStar Medical Holding Corporation | - USD | Infinity% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | -10773481.56% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | -420.816% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 101.788% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | 15720.308% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | 117.1% |
| TG Therapeutics, Inc. | 219.1 Million USD | 127.732% |
| Galecto, Inc. | -830 Thousand USD | -7220.843% |
| Calithera Biosciences, Inc. | -1.38 Million USD | -4287.22% |
| Fortrea Holdings Inc. | 424 Million USD | 114.331% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 29.482% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | -10616.578% |
| XBiotech Inc. | -1.74 Million USD | -3384.117% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | -5384.025% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | -30.755% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 19.555% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | 182.78% |
| Theravance Biopharma, Inc. | 16.8 Million USD | 461.62% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | 115.619% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | -22.39% |
| Vaxxinity, Inc. | -2.23 Million USD | -2619.919% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | 118.596% |
| Gain Therapeutics, Inc. | -11.32 Million USD | -436.593% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | 348.509% |
| NexImmune, Inc. | -1.02 Million USD | -5828.26% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | 1125340.741% |
| Marker Therapeutics, Inc. | -7.1 Million USD | -755.136% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 100.538% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | -90825.823% |
| Scopus BioPharma Inc. | - USD | Infinity% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | -1611.152% |
| Ainos, Inc. | -253.73 Thousand USD | -23847.614% |
| Pluri Inc. | 322 Thousand USD | 18970.497% |
| Prothena Corporation plc | -129.2 Million USD | 52.97% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | 220.504% |
| Celularity Inc. | 6.75 Million USD | 999.526% |
| Rallybio Corporation | -150 Thousand USD | -40408.667% |
| Cue Biopharma, Inc. | -32.6 Million USD | -86.35% |
| MeiraGTx Holdings plc | 287 Thousand USD | 21271.777% |
| Omeros Corporation | -69.77 Million USD | 12.921% |
| Humacyte, Inc. | -76.55 Million USD | 20.623% |
| Immunocore Holdings plc | 248.39 Million USD | 124.463% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | -300.574% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | 197.405% |
| Blueprint Medicines Corporation | 236.58 Million USD | 125.683% |
| CalciMedica, Inc. | -58 Thousand USD | -104663.793% |
| Cabaletta Bio, Inc. | -1.42 Million USD | -4161.08% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | 309.131% |
| Scholar Rock Holding Corporation | -2.84 Million USD | -2036.533% |
| Sana Biotechnology, Inc. | -30.86 Million USD | -96.867% |
| Pulmatrix, Inc. | -8.22 Million USD | -639.209% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | -5093.419% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | -15128.822% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 84.763% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | 2289.196% |
| Cytokinetics, Incorporated | -322.59 Million USD | 81.164% |
| Eloxx Pharmaceuticals, Inc. | - USD | Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | 7148.213% |
| Protara Therapeutics, Inc. | -341 Thousand USD | -17719.062% |
| Vor Biopharma Inc. | -3.49 Million USD | -1640.063% |
| Roivant Sciences Ltd. | 109.23 Million USD | 155.626% |
| Evogene Ltd. | 1.39 Million USD | 4443.317% |
| ProKidney Corp. | -3.16 Million USD | -1817.419% |
| Applied Therapeutics, Inc. | -43.91 Million USD | -38.374% |
| Hoth Therapeutics, Inc. | - USD | Infinity% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | 986.146% |
| CorMedix Inc. | -205.56 Thousand USD | -29459.452% |
| BioLineRx Ltd. | 1.1 Million USD | 5584.025% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 22.763% |
| Galectin Therapeutics Inc. | -33 Thousand USD | -184030.303% |
| Atai Life Sciences N.V. | -5000.00 USD | -1215160.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | -49763.367% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | -63194.792% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | -4274.586% |
| Sagimet Biosciences Inc. | 2 Million USD | 3138.15% |
| MediciNova, Inc. | 979.7 Thousand USD | 6302.173% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 27.937% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | -64162.07% |
| GeoVax Labs, Inc. | -20.72 Million USD | -193.247% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | 124.848% |
| Biomea Fusion, Inc. | -4.2 Million USD | -1346.394% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 106.966% |
| Mereo BioPharma Group plc | 7.42 Million USD | 918.247% |
| Cullinan Oncology, Inc. | -310 Thousand USD | -19500.968% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | -506258.333% |
| Absci Corporation | -41.84 Million USD | -45.196% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | -1215160.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 20.439% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | -2369.037% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | 128.429% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | -6357.279% |
| Allakos Inc. | -6.14 Million USD | -889.464% |
| Imunon, Inc. | -720 Thousand USD | -8339.247% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | 11.933% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | 112.768% |
| BioAtla, Inc. | -103.73 Million USD | 41.423% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | -532534.993% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | -34036.517% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 74.976% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | -19437.942% |
| XOMA Corporation | 3.86 Million USD | 1673.763% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | 13.301% |
| Cara Therapeutics, Inc. | 14.79 Million USD | 510.727% |
| aTyr Pharma, Inc. | -2.38 Million USD | -2444.514% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | 587.665% |
| Akero Therapeutics, Inc. | -29 Thousand USD | -209427.586% |
| Viridian Therapeutics, Inc. | -1 Million USD | -5928.075% |
| Eliem Therapeutics, Inc. | - USD | Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | 467407792.308% |
| Akari Therapeutics, Plc | -4000.00 USD | -1518975.0% |
| Tevogen Bio Holdings Inc. | - USD | Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 109.541% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | 31307.244% |
| UroGen Pharma Ltd. | 73.35 Million USD | 182.838% |
| Sutro Biopharma, Inc. | -26.69 Million USD | -127.628% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | 523467.786% |
| Orgenesis Inc. | -5.72 Million USD | -961.362% |
| Entera Bio Ltd. | -56 Thousand USD | -108405.357% |
| GH Research PLC | -315 Thousand USD | -19189.841% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | -32049.735% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | -11473.905% |
| Xencor, Inc. | -85.26 Million USD | 28.732% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | -27397.432% |
| Replimune Group, Inc. | -2.65 Million USD | -2188.625% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | -5968.799% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | 134.166% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | 31307.244% |
| Portage Biotech Inc. | -54 Thousand USD | -112424.074% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | -64162.07% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | -16017.507% |
| OncoCyte Corporation | 413 Thousand USD | 14812.591% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | -1351690.879% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | -27370620.721% |
| Purple Biotech Ltd. | -196 Thousand USD | -30901.531% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | 777.554% |
| scPharmaceuticals Inc. | 9.78 Million USD | 721.172% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | -481.745% |
| HilleVax, Inc. | -2.15 Million USD | -2718.321% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | -62542.268% |
| Tharimmune, Inc. | - USD | Infinity% |
| Genprex, Inc. | -15 Thousand USD | -404878.672% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | -8996.257% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | -264086.957% |
| XTL Biopharmaceuticals Ltd. | - USD | Infinity% |
| Virios Therapeutics, Inc. | - USD | Infinity% |
| OKYO Pharma Limited | -7506.16 USD | -809408.457% |
| Savara Inc. | -44.26 Million USD | -37.28% |
| Curis, Inc. | 9.81 Million USD | 719.335% |
| Daré Bioscience, Inc. | 2.76 Million USD | 2293.989% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | -48592.983% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | -3414.344% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | -26550.439% |
| BeiGene, Ltd. | 2.07 Billion USD | 102.923% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | -2073.289% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 84.796% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | 207.188% |
| Erasca, Inc. | -3.73 Million USD | -1528.162% |
| bluebird bio, Inc. | -4.03 Million USD | -1407.767% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | -215234.184% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 103.191% |
| DBV Technologies S.A. | 15.72 Million USD | 486.336% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | -215234.184% |
| Moderna, Inc. | 2.15 Billion USD | 102.82% |
| Vincerx Pharma, Inc. | -915 Thousand USD | -6540.765% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | 858.968% |
| Molecular Templates, Inc. | 50.39 Million USD | 220.573% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | -11236.381% |
| Travere Therapeutics, Inc. | 133.78 Million USD | 145.417% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | -876.583% |
| Spruce Biosciences, Inc. | -39.34 Million USD | -54.444% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 45.322% |
| Cogent Biosciences, Inc. | -3.58 Million USD | -1593.506% |
| MacroGenics, Inc. | 50.52 Million USD | 220.258% |
| RenovoRx, Inc. | - USD | Infinity% |
| Adicet Bio, Inc. | -6.09 Million USD | -896.441% |
| Prime Medicine, Inc. | -147.9 Million USD | 58.918% |
| Aditxt, Inc. | -111.66 Thousand USD | -54317.876% |
| Adagene Inc. | 18.11 Million USD | 435.494% |
| Estrella Immunopharma, Inc. | - USD | Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | 12551.434% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | 143.34% |
| Acurx Pharmaceuticals, Inc. | - USD | Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | 138.498% |
| SciSparc Ltd. | 2.19 Million USD | 2866.985% |
| Vericel Corporation | 135.57 Million USD | 144.818% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | -242476.55% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | -196023.556% |
| Generation Bio Co. | -73.91 Million USD | 17.789% |
| Astria Therapeutics, Inc. | - USD | Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | -13804.577% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | 211.249% |
| Invivyd, Inc. | -2.02 Million USD | -2896.203% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 79.802% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | -58643.402% |
| Spero Therapeutics, Inc. | 96.36 Million USD | 163.053% |
| Artelo Biosciences, Inc. | - USD | Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | 161.821% |
| ADMA Biologics, Inc. | 88.21 Million USD | 168.878% |
| Clene Inc. | 533 Thousand USD | 11500.188% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | 352.033% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | -6249.321% |
| GeoVax Labs, Inc. | -20.72 Million USD | -193.247% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | 3156.489% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | -31170.199% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | 222.002% |
| Relmada Therapeutics, Inc. | - USD | Infinity% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | -756.782% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | -7168.301% |
| Vir Biotechnology, Inc. | 83.41 Million USD | 172.844% |
| Evaxion Biotech A/S | 73.11 Thousand USD | 83209.476% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | 214.298% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 64.915% |
| Trevena, Inc. | 1.45 Million USD | 4276.151% |
| Surrozen, Inc. | -27.23 Million USD | -123.147% |
| Tyra Biosciences, Inc. | -353 Thousand USD | -17113.314% |
| Cingulate Inc. | -582.91 Thousand USD | -10323.936% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | -195909.677% |
| Unity Biotechnology, Inc. | -19.69 Million USD | -208.457% |
| Tenax Therapeutics, Inc. | -7570.00 USD | -802581.638% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | -6797.049% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 108.926% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | -6050.101% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | -107746.722% |
| Kronos Bio, Inc. | 1.37 Million USD | 4528.79% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | -13.224% |
| CERo Therapeutics Holdings, Inc. | - USD | Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | -20709.247% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | -12343.428% |
| ImmunityBio, Inc. | -17.89 Million USD | -239.648% |
| Korro Bio, Inc. | -3.63 Million USD | -1573.912% |
| Kineta, Inc. | 5.43 Million USD | 1218.406% |
| BioVie Inc. | -229.37 Thousand USD | -26390.45% |
| Codexis, Inc. | 57.33 Million USD | 205.981% |
| Celularity Inc. | 6.75 Million USD | 999.526% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | 1614.154% |
| Celcuity Inc. | -142.77 Thousand USD | -42459.465% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | 120208.717% |
| Cibus, Inc. | 1.42 Million USD | 4373.066% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | -16146.791% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | -165.121% |
| IN8bio, Inc. | -2.5 Million USD | -2329.548% |
| Kodiak Sciences Inc. | -25.94 Million USD | -134.181% |
| Annexon, Inc. | -3.26 Million USD | -1759.902% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | -2872.75% |
| Assembly Biosciences, Inc. | -41.73 Million USD | -45.585% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | 9594.219% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 107.805% |
| Eyenovia, Inc. | - USD | Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | 135.132% |
| Conduit Pharmaceuticals Inc. | - USD | Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | -3098.053% |
| Arcellx, Inc. | 108.27 Million USD | 156.117% |
| Cardiff Oncology, Inc. | -32.36 Million USD | -87.72% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | 176.717% |
| Regulus Therapeutics Inc. | -21.15 Million USD | -187.268% |
| Moolec Science SA | -143.3 Thousand USD | -42301.172% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | -43.587% |
| Geron Corporation | -123.5 Million USD | 50.8% |
| LAVA Therapeutics N.V. | 3.28 Million USD | 1948.585% |
| Royalty Pharma plc | 1.79 Billion USD | 103.387% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | 13.307% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | -1682153.599% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | 26359.88% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 45.462% |
| Humacyte, Inc. | -76.55 Million USD | 20.623% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | -6301.671% |
| 89bio, Inc. | -273 Thousand USD | -22157.509% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | -4733.97% |
| Avenue Therapeutics, Inc. | - USD | Infinity% |
| Genelux Corporation | -848 Thousand USD | -7065.448% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | -49300.813% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | 5530.116% |
| Notable Labs, Ltd. | 113 Thousand USD | 53872.566% |
| Liquidia Corporation | 14.6 Million USD | 516.185% |
| Mustang Bio, Inc. | -2.22 Million USD | -2630.921% |
| Immunovant, Inc. | -231 Thousand USD | -26204.329% |
| Quantum-Si incorporated | 488 Thousand USD | 12551.434% |
| Arbutus Biopharma Corporation | -55.55 Million USD | -9.367% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | -202443.333% |
| Vera Therapeutics, Inc. | 1.86 Million USD | 3363.319% |
| Acasti Pharma Inc. | -11 Thousand USD | -552290.909% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | -29595.969% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | -9270.441% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 63.726% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | 5455.55% |
| NeuroBo Pharmaceuticals, Inc. | - USD | Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | -15848.294% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | -3003.32% |
| PepGen Inc. | -1.18 Million USD | -5032.01% |
| Moleculin Biotech, Inc. | -127 Thousand USD | -47744.882% |
| United Therapeutics Corporation | 2.07 Billion USD | 102.935% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -165.375% |
| Solid Biosciences Inc. | -76.56 Million USD | 20.637% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | -73478.097% |
| Immuneering Corporation | -764.13 Thousand USD | -7851.836% |
| Lixte Biotechnology Holdings, Inc. | - USD | Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | 91798.358% |
| Belite Bio, Inc | -399 Thousand USD | -15128.822% |
| XOMA Corporation | 3.86 Million USD | 1673.763% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | -203.269% |
| Bionomics Limited | -434.44 Thousand USD | -13886.222% |
| Apogee Therapeutics, Inc. | - USD | Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | -5557.635% |
| uniQure N.V. | 2.21 Million USD | 2843.251% |
| Cassava Sciences, Inc. | -89.42 Million USD | 32.05% |
| Estrella Immunopharma, Inc. | - USD | Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 34.003% |
| Forte Biosciences, Inc. | -9000.00 USD | -675044.444% |
| Anebulo Pharmaceuticals, Inc. | - USD | Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | -7177.006% |
| Conduit Pharmaceuticals Inc. | - USD | Infinity% |
| SeaStar Medical Holding Corporation | - USD | Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | -13804.577% |
| Altimmune, Inc. | -65.37 Million USD | 7.052% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | 116.784% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | -5557.635% |
| Compugen Ltd. | 31.45 Million USD | 293.174% |
| Peak Bio, Inc. | 367.76 Thousand USD | 16622.056% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | 347.85% |
| Benitec Biopharma Inc. | 108 Thousand USD | 56362.037% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | -77801.282% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | -4950.956% |
| Zura Bio Limited | - USD | Infinity% |
| PolyPid Ltd. | -1.82 Million USD | -3234.962% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | -50961.345% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | -4950.956% |
| Instil Bio, Inc. | -4.75 Million USD | -1177.607% |
| argenx SE | 1.1 Billion USD | 105.482% |
| Immunome, Inc. | -8.9 Million USD | -582.194% |
| Compass Therapeutics, Inc. | -1.89 Million USD | -3114.974% |
| Verona Pharma plc | -679.62 Thousand USD | -8840.679% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | -34621.714% |
| Shattuck Labs, Inc. | -2.38 Million USD | -2447.715% |
| CervoMed Inc. | -1.29 Million USD | -4597.104% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | -2424.429% |
| Plus Therapeutics, Inc. | -4.77 Million USD | -1171.991% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | 2559.045% |
| Moolec Science SA | -143.3 Thousand USD | -42301.172% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | -14791.797% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | -2174.466% |
| AnaptysBio, Inc. | 14.78 Million USD | 511.089% |
| Design Therapeutics, Inc. | -537 Thousand USD | -11215.27% |
| Leap Therapeutics, Inc. | -427 Thousand USD | -14130.211% |
| NeurAxis, Inc. | 2.15 Million USD | 2917.401% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | 2931.454% |
| Lumos Pharma, Inc. | 2 Million USD | 3127.554% |
| Achilles Therapeutics plc | -4.73 Million USD | -1184.286% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | -34621.714% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | -57399.882% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | 291.931% |
| CERo Therapeutics Holdings, Inc. | - USD | Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | 7148.213% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | -5787.888% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | -33.404% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | 141409.302% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | -7292.092% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | -461695.106% |
| Palisade Bio, Inc. | 246 Thousand USD | 24800.407% |
| Tourmaline Bio, Inc. | -33 Thousand USD | -184030.303% |
| Beam Therapeutics Inc. | -59.67 Million USD | -1.828% |
| Neurogene Inc. | -3.26 Million USD | -1762.753% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | 143.609% |
| AEON Biopharma, Inc. | - USD | Infinity% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | -1545.802% |
| Sesen Bio, Inc. | 40 Million USD | 251.908% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | -20358.923% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | -1408.876% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | -535.198% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | 531.555% |
| Athira Pharma, Inc. | -969 Thousand USD | -6170.691% |
| Vaccinex, Inc. | -16 Million USD | -279.674% |
| HCW Biologics Inc. | -574.82 Thousand USD | -10470.714% |
| XOMA Corporation | 3.86 Million USD | 1673.763% |
| Nektar Therapeutics | 53.47 Million USD | 213.622% |
| Arvinas, Inc. | 71.8 Million USD | 184.628% |
| Tevogen Bio Holdings Inc. | - USD | Infinity% |
| Merus N.V. | -83.46 Million USD | 27.196% |
| Omega Therapeutics, Inc. | -62.77 Million USD | 3.205% |
| Quince Therapeutics, Inc. | -322 Thousand USD | -18770.497% |
| Rezolute, Inc. | -36 Thousand USD | -168686.111% |
| Clene Inc. | 533 Thousand USD | 11500.188% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | -4732220.872% |
| BeyondSpring Inc. | 1.75 Million USD | 3570.188% |
| Synlogic, Inc. | -1.92 Million USD | -3058.16% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | -164124.324% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | -859.618% |
| Peak Bio, Inc. | 367.76 Thousand USD | 16622.056% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | -220.429% |
| Krystal Biotech, Inc. | 47.6 Million USD | 227.64% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | 143.067% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | 1309.214% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | -2246.769% |
| MannKind Corporation | 136.19 Million USD | 144.616% |
| Ikena Oncology, Inc. | -50.49 Million USD | -20.342% |
| Cyclerion Therapeutics, Inc. | - USD | Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | 155.841% |
| Gossamer Bio, Inc. | -4.38 Million USD | -1285.701% |
| CohBar, Inc. | - USD | Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | -24012.302% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | -1215160.0% |
| Legend Biotech Corporation | 140.92 Million USD | 143.116% |
| Mural Oncology plc | -2.56 Million USD | -2267.082% |
| Biora Therapeutics, Inc. | -551 Thousand USD | -10927.768% |
| PaxMedica, Inc. Common Stock | - USD | Infinity% |
| Disc Medicine, Inc. | -100 Thousand USD | -60663.0% |
| Champions Oncology, Inc. | 20.75 Million USD | 392.777% |
| REGENXBIO Inc. | 53.02 Million USD | 214.584% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | -1034.283% |
| Anavex Life Sciences Corp. | - USD | Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | -31485.705% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | -3408.256% |
| PharmaCyte Biotech, Inc. | - USD | Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | -23023.145% |
| Cellectis S.A. | 18 Thousand USD | 337672.222% |
| Longeveron Inc. | 221 Thousand USD | 27594.57% |
| Repare Therapeutics Inc. | -80.07 Million USD | 24.113% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 105.559% |
| Inozyme Pharma, Inc. | -1.29 Million USD | -4595.75% |
| Revolution Medicines, Inc. | -399.66 Million USD | 84.796% |
| Nymox Pharmaceutical Corporation | - USD | Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | -173508.571% |
| ArriVent BioPharma, Inc. Common Stock | - USD | Infinity% |
| AN2 Therapeutics, Inc. | - USD | Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | 124106.122% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 100.706% |
| Denali Therapeutics Inc. | -93.34 Million USD | 34.905% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | -242476.55% |
| Veru Inc. | 7.56 Million USD | 903.114% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | -40140.397% |
| Cingulate Inc. | -582.91 Thousand USD | -10323.936% |
| Passage Bio, Inc. | -3.72 Million USD | -1532.975% |
| Context Therapeutics Inc. | -12.04 Thousand USD | -504408.469% |
| Exicure, Inc. | -1.42 Million USD | -4170.063% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | -15765.013% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | 2347.984% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | -11752.148% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | 189.192% |
| Nuvalent, Inc. | - USD | Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | -40515.078% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | -2.63% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | 15640.409% |
| OmniAb, Inc. | 14.66 Million USD | 514.284% |
| Anew Medical, Inc. | - USD | Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | 403.921% |
| Lipocine Inc. | -2.85 Million USD | -2031.423% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | -3196.961% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | -965.083% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | -3933.948% |
| G1 Therapeutics, Inc. | 75.31 Million USD | 180.677% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | -93381.538% |
| Sage Therapeutics, Inc. | 84.29 Million USD | 172.083% |
| Ocugen, Inc. | -33.53 Million USD | -81.182% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | -1821.664% |
| Q32 Bio Inc. | 578 Thousand USD | 10612.63% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | -22829.434% |
| Alumis Inc. Common Stock | -1.28 Million USD | -4632.321% |
| Equillium, Inc. | 35.95 Million USD | 268.983% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | -3459.637% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | 12236.119% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | -1469735.51% |
| Galera Therapeutics, Inc. | -259 Thousand USD | -23360.618% |
| Evelo Biosciences, Inc. | - USD | Infinity% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | 14474.562% |
| Dominari Holdings Inc. | 2.03 Million USD | 3080.039% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | -33018.585% |
| vTv Therapeutics Inc. | -13.59 Million USD | -346.951% |
| Bio-Techne Corporation | 773.07 Million USD | 107.86% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | 450.846% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | 113.187% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | -5097.861% |
| Candel Therapeutics, Inc. | -23.98 Million USD | -153.39% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | 619.475% |
| Nkarta, Inc. | -5.86 Million USD | -935.321% |
| BioCardia, Inc. | -7.24 Million USD | -738.226% |
| Iterum Therapeutics plc | -1.75 Million USD | -3372.171% |